Why We Funded AI Ethics Education for Research Oversight —and Left the Agenda to PRIM&R
As AI becomes part of research workflows, the people responsible for ethical oversight need opportunities to examine its implications together
AI in Clinical Trials
Advarra’s Perspective on FDA’s Draft AI Guidance: Advancing Responsible Innovation
The U.S. Food and Drug Administration’s (FDA’s) recent draft guidance, “Considerations for the Use of Artificial Intelligence to Support Regulatory